Alpha Teknova, Inc.

General Information

We are a leading provider of critical reagents that enable the discovery, development and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Our 3,000 active customers span the continuum of the life sciences market, including leading pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Our company is built around proprietary development and manufacturing processes that are highly adaptable and versatile. These proprietary processes enable us to manufacture and deliver high quality, custom, made-to-order products on a short turnaround time and at scale, across all stages of our customers’ product development, including commercialization.

(Note: Alpha Teknova upsized its IPO at pricing on June 24, 2021, to 6 million shares – up from 5 million shares in the prospectus – at $16 – the top of its $14-to-$16 price range – to raise $96 million.)

Industry: Biological Products
Employees: 194
Founded: 1996
Contact Information
Address 2290 Bert Dr., Hollister, California 95023, US
Phone Number (831) 637-1100
Web Address
View Prospectus: Alpha Teknova, Inc.
Financial Information
Market Cap $391.2mil
Revenues $34.3 mil (last 12 months)
Net Income $-0.2 mil (last 12 months)
IPO Profile
Symbol TKNO
Exchange NASDAQ
Shares (millions): 6.0
Price range $16.00 - $16.00
Est. $ Volume $96.0 mil
Manager / Joint Managers Cowen and Company/ William Blair
CO-Managers BTIG/ Stephens, Inc.
Expected To Trade: 6/25/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change